{"organizations": [], "uuid": "6c51e02aeb5d9ddc2eaa44a266093cf4f43dbb4e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-integra-lifesciences-holdings-repo/brief-integra-lifesciences-holdings-reports-q4-eps-of-0-56-idUSL8N1QH5YD", "country": "US", "domain_rank": 408, "title": "BRIEF-Integra Lifesciences Holdings Reports Q4 EPS Of $0.56", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-27T15:53:00.000+02:00", "replies_count": 0, "uuid": "6c51e02aeb5d9ddc2eaa44a266093cf4f43dbb4e"}, "author": "", "url": "https://www.reuters.com/article/brief-integra-lifesciences-holdings-repo/brief-integra-lifesciences-holdings-reports-q4-eps-of-0-56-idUSL8N1QH5YD", "ord_in_thread": 0, "title": "BRIEF-Integra Lifesciences Holdings Reports Q4 EPS Of $0.56", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-integra lifesciences holdings", "sentiment": "negative"}, {"name": "integra lifesciences holdings corp", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 27, 2018 / 1:54 PM / Updated 8 minutes ago BRIEF-Integra Lifesciences Holdings Reports Q4 EPS Of $0.56 Reuters Staff Feb 27 (Reuters) - Integra Lifesciences Holdings Corp : * INTEGRA LIFESCIENCES REPORTS FOURTH QUARTER AND FULL-YEAR 2017 FINANCIAL RESULTS * Q4 ADJUSTED EARNINGS PER SHARE $0.64 * Q4 GAAP EARNINGS PER SHARE $0.56 * Q4 REVENUE ROSE 44.2 PERCENT TO $368.6 MILLION * INTEGRA LIFESCIENCES HOLDINGS SEES FY 2018 REVENUE TO BE AT HIGH END OF $1.46 BILLION TO $1.48 BILLION * SEES FY 2018 GAAP EARNINGS PER SHARE $0.60 TO $0.70 * SAYS FY 2018 ADJUSTED EARNINGS PER SHARE TO BE AT HIGH END OF PREVIOUSLY PROVIDED RANGE OF $2.25 TO $2.35 * SAYS EXPECT Q1 ORGANIC GROWTH TO BE IN LOW SINGLE-DIGITS * FY2018 EARNINGS PER SHARE VIEW $2.30, REVENUE VIEW $1.47 BILLION -- THOMSON REUTERS I/B/E/S * Q4 EARNINGS PER SHARE VIEW $0.56, REVENUE VIEW $356.4 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-27T15:53:00.000+02:00", "crawled": "2018-02-27T16:08:44.005+02:00", "highlightTitle": ""}